Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × OTHER × Advanced Breast Cancer × Clear all

Phase

Phase 2 25 Phase NA 5 Phase 3 4 Phase 1 3 Phase 2/3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 267 Leukemia, Myeloid, Acute 221 Multiple Myeloma 192 Carcinoma, Non-Small-Cell Lung 192 Prostatic Neoplasms 171 Neoplasms 170 Lymphoma 156 Colorectal Neoplasms 153 Melanoma 150 Leukemia 142 Pancreatic Neoplasms 138 Precursor Cell Lymphoblastic Leukemia-Lymphoma 137 Lung Neoplasms 127 Recurrence 125 Glioblastoma 116 Neoplasm Metastasis 114 Lymphoma, Non-Hodgkin 109 Ovarian Neoplasms 104 Myelodysplastic Syndromes 98 Leukemia, Lymphocytic, Chronic, B-Cell 98 Lymphoma, Large B-Cell, Diffuse 92 Carcinoma, Hepatocellular 85 Lymphoma, Mantle-Cell 84 Brain Neoplasms 80 Stomach Neoplasms 79 Hodgkin Disease 79 Lymphoma, Follicular 77 Carcinoma, Renal Cell 72 Sarcoma 69 Squamous Cell Carcinoma of Head and Neck 59

Interventions

sacituzumab govitecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06612203 2025-12-05

WIN-B

MedSIR

Phase 1/2 Active not recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡